|
AZV ERDERA
Call from the European Rare Diseases Partnership (ERDERA)
Is your research focused on therapies using small molecules, small non-coding chemically synthesized nucleic acids, repurposed drugs, or biological substances (e.g., antibodies or proteins such as enzymes, immune modulators, or growth factors, etc.)?
Then you might be interested in the call from the European Rare Diseases Partnership (ERDERA). The call "Pre-clinical therapy studies for rare diseases using small molecules and biologicals – development and validation" is focused on supporting international consortia consisting of 4-6 partners. The call is published as a pre-announcement, with the expected launch date on December 10, 2024. If you're interested, please contact projekty@med.muni.cz.
|
